Filtered By:
Vaccination: AIDS Vaccine
This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 1692 results found since Jan 2013.
50 Years of Achievements and Persistent Challenges for Biomedical and Health Informatics and John Mantas' Educational and Nursing Informatics Contributions
Stud Health Technol Inform. 2022 Oct 26;300:1-11. doi: 10.3233/SHTI220936.ABSTRACTBiomedical and Health Informatics (BMHI) have been essential catalysts for achievements in medical research and healthcare applications over the past 50 years. These include increasingly sophisticated information systems and data bases for documentation and processing, standardization of biomedical data, nomenclatures, and vocabularies to assist with large scale literature indexing and text analysis for information retrieval, and methods for computationally modeling and analyzing research and clinical data. Statistical and AI techniques for d...
Source: Studies in Health Technology and Informatics - October 27, 2022 Category: Information Technology Authors: Casimir A Kulikowski Source Type: research
Dr. Anthony Fauci Is Stepping Down. Here ’s His Advice For His Successor
After Dr. Anthony Fauci steps down as head of the National Institute of Allergy and Infectious Diseases (NIAID) and chief medical advisor to President Biden on Dec. 31, he’ll leave behind a long and storied career. Ahead of his last day, he spoke to TIME from his office at the National Institutes of Health about what’s next for him—and his advice for whoever fills his shoes.
This interview has been edited and condensed for clarity.
TIME: You’re leaving your leadership positions in the federal government, but you aren’t retiring. What are you calling the next stage in your career?
[time-brightc...
Source: TIME: Health - December 20, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
LEIDEN, THE NETHERLANDS, (January 18, 2023) – The Janssen Pharmaceutical Companies of Johnson & Johnson, together with a consortium of global partners, today announced the results of an independent, scheduled data review of the Phase 3 Mosaico study (also known as HPX3002/HVTN706) of Janssen’s investigational HIV vaccine regimen. The study’s independent Data and Safety Monitoring Board (DSMB) determined that the regimen was not effective in preventing HIV infection compared to placebo among study participants. No safety issues with the vaccine regimen were identified.In light of the DSMB’s determination, the Mo...
Source: Johnson and Johnson - January 18, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Lower-extremity Dynamometry as a Novel Outcome Measure in a Double-blind, Placebo-controlled, Feasibility Trial of Intravenous Immunoglobulin (IVIG) for HIV-associated Myelopathy
Conclusion: We conclude that an adequately powered clinical trial of IVIG for HIVM would likely require a prolonged recruitment period and multiple participating sites. Lower limb dynamometry is a useful outcome measure for HIVM, which might also be useful in other HIV-related gait disorders.
KEYWORDS: Dynamometry, intravenous immunoglobulin (IVIG), human immunodeficiency virus (HIV), myelopathy
INTRODUCTION
Human immunodeficiency virus (HIV)-associated myelopathy (HIVM) is a rare but well-described neurologic complication of HIV; it was first described early in the acquired immunodeficiency syndrome (AIDS) epidemic, and i...
Source: Innovations in Clinical Neuroscience - February 1, 2018 Category: Neuroscience Authors: ICN Online Editor Tags: Assessment Tools Current Issue Demyelinating Disease Movement Disorders Neurodegenerative Disease Neurology Original Research Primary Care Technology Trial Methodology Dynamometry human immunodeficiency virus (HIV) intravenous immu Source Type: research
Immunological Changes in Monocyte Subsets and Their Association With Foxp3+ Regulatory T Cells in HIV-1-Infected Individuals With Syphilis: A Brief Research Report
This study and other related experiments were approved by the Beijing Youan Hospital Research Ethics Committee, and informed consent was obtained in accordance with the Declaration of Helsinki. The study was carried out in accordance with approved guidelines and regulations.
Author Contributions
BS, LfL, TZ, and HW conceived the study, designed the experiments, and analyzed the data. NG, XY, TS, LL, and GL performed the experiments. LfL, TJ, YG, TZ, BS, and HW contributed to reagents and materials. NG, LfL, and BS wrote the article. All authors read and approved the final manuscript.
Funding
This work was supported by ...
Source: Frontiers in Immunology - April 8, 2019 Category: Allergy & Immunology Source Type: research
Religion & the Pandemic: A Call Beyond the Here & Now
Religions for Peace Interreligious Council of Albania distributing Covid relief supplies from the Multi-religious Humanitarian Fund. Credit: Erzen CarjaBy Prof. Azza KaramNEW YORK, Aug 4 2020 (IPS) — I have never been interested in religion or spirituality before, but I found myself tuning in to all sorts of on-line religion and spirituality related forums “in search of something.”
These are the words of a 30-something single young, middle class man (born into a Protestant-Catholic family background) in a European country.
The latter is known more for turning several churches into museums or shopping centers, p...
Source: IPS Inter Press Service - Health - August 4, 2020 Category: International Medicine & Public Health Authors: Azza Karam Tags: Civil Society Featured Global Headlines Health Human Rights Humanitarian Emergencies Inequity Religion TerraViva United Nations Source Type: news
Anthony Fauci, 100 Days Into the Biden Administration, Is Finally Getting to Do His Job
When Dr. Anthony Fauci arrived at 1600 Pennsylvania Ave. for his first White House press briefing under the new Biden Administration, he could see things would be different.
It was the day after the Inauguration, and President Joe Biden was eager to get the country’s COVID-19 response back on track. Five minutes before he addressed the public, Fauci spoke with the new President. “He said, ‘I want you to just go and tell the science, explain to people that if we make mistakes, we’re going to fix the mistakes and we’re not going to dwell on the mistakes. Let science be communicated to the public...
Source: TIME: Health - May 18, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Deciphering the impact of novel coronavirus pandemic on agricultural sustainability, food security, and socio-economic sectors-a review
In conclusion, we should strictly follow SOP's to improve our agriculture, education, economy, and other ways of normal life. We should also be vaccinated to fulfill our all losses in different fields.PMID:34333745 | DOI:10.1007/s11356-021-15728-y
Source: Environmental Science and Pollution Research International - August 1, 2021 Category: Environmental Health Authors: Mehvish Mumtaz Nazim Hussain Zulqarnain Baqar Saima Anwar Muhammad Bilal Source Type: research
U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen
TITUSVILLE, N.J., March 29, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (cabotegravir and rilpivirine) for the treatment of HIV-1 in virologically suppressed adolescents (HIV-1 RNA less than 50 copies per milliliter [c/mL]) who are 12 years of age or older, weigh at least 35 kg and are on a stable antiretroviral regimen, with no history of treatment failure, nor known or suspected resistance to either cabotegravir or rilpivirine.1,2 Co-developed as part of a collaboration with ViiV Healthcare, CABENUVA is the first ...
Source: Johnson and Johnson - March 30, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Research Using Fetal Tissue
Hello HuffPo! Some of you may know me from junkscience.com or healthnewsdigest.com. My main focus here will be on science, or what passes for science these days. Many people of good will are not aware that our government spends more than $400 billion per year on R & D. Regrettably, a substantial amount of that ends of being little more than a form of academic welfare, for research that has almost no chance of ever leading to anything practical, and in many cases does not even add to so-called "basic knowledge." By way of example (and I will have many more), let's take a look at a current hot topic: Research using fetal tis...
Source: Science - The Huffington Post - September 1, 2015 Category: Science Source Type: news
How Activists Changed The Federal Approach To AIDS Research Forever
When Dr. Anthony Fauci first became director of the National Institute of Allergies and Infectious Diseases in 1984, hundreds of people in the U.S. had already died from a mysterious and terrifying disease we now know to be HIV/AIDS. But even though the NIAID was in charge of finding treatments, vaccines and cures for communicable diseases, Fauci said his agency failed to act quickly enough in its search for effective medicines. The traditional research-to-pharmaceutical pipeline, of which Fauci remained staunchly in favor until a dramatic change of heart, took several years from start to finish -- and people with HIV...
Source: Healthy Living - The Huffington Post - December 1, 2015 Category: Consumer Health News Source Type: news
Can Uttar Pradesh Improve Its Health Care Indicators with mSakhi?
This article originally appeared in Newslaundry and can be accessed here.
ByByBiraj Swaindigital healthmaternal, newborn,& child healthcommunity health workersIndia
Source: IntraHealth International - December 8, 2016 Category: Global & Universal Authors: intrahealth Source Type: news
PPPs Likely to Undermine Public Health Commitments
Capacity-building support for developing countries to safeguard the public interest in terms of public health and especially, to ensure that no one is left behind, is essential. Credit: IPSBy Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR , Jan 17 2018 (IPS)The United Nations Agenda 2030 for the Sustainable Development Goals (SDGs) is being touted in financial circles as offering huge investment opportunities requiring trillions of dollars. In 67 low- and middle-income countries, achieving SDG 3 — healthy lives and well-being for all, at all ages — is estimated to require new investments increasing over ...
Source: IPS Inter Press Service - Health - January 17, 2018 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Development & Aid Economy & Trade Featured Global Headlines Health Poverty & SDGs TerraViva United Nations Trade & Investment Water & Sanitation Source Type: news
